MA18.10 Phase 2 Multicohort Study of CC-90011, a LSD1 Inhibitor, in Combination with Nivolumab in Patients with Advanced Lung Cancer
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: C.M. Rudin, A. Navarro, E. Carcereny, L.C. Villaruz, G. Lo Russo, C. Ricordel, A. Bearz, J. Li, I. Elias, A. Bhingare, E. Morris, S. Popat
Institutions: Memorial Sloan Kettering Cancer Center, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Institut Català d'Oncologia, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Centre Hospitalier Universitaire de Rennes, Centro di Riferimento Oncologico, Bristol-Myers Squibb (United States), Royal Marsden NHS Foundation Trust, Royal Marsden Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388046069